Production of interleukin-1-receptor antagonist during experimental endotoxaemia
- 1 December 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 338 (8780) , 1423-1424
- https://doi.org/10.1016/0140-6736(91)92725-h
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulatedBlood, 1991
- Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptorJournal of Biological Chemistry, 1991
- Interleukin-1 and interleukin-1 antagonismBlood, 1991
- A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbitsThe FASEB Journal, 1991
- Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.Journal of Clinical Investigation, 1990
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1.Proceedings of the National Academy of Sciences, 1989
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- SPECIFIC INTERLEUKIN-1 INHIBITOR IN SERUM AND URINE OF CHILDREN WITH SYSTEMIC JUVENILE CHRONIC ARTHRITISThe Lancet, 1987
- A urine inhibitor of interleukin 1 activity that blocks ligand binding.The Journal of Immunology, 1987